Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gregory Fryer Associates was a UK-based clinical and regulatory consultancy established in 2003. It specialized in supporting pharmaceutical and biotech companies with regulatory submissions for clinical trials across Europe. The firm handled approximately 30–40 Clinical Trial Application filings per year between 2004–2009, covering Phases I to III studies involving advanced therapies, new chemical entities, biotechnology products, and known actives. Clients included both EU-based firms and international companies seeking European trial approvals. The UK legal entity "GREGORY FRYER ASSOCIATES LIMITED" was incorporated in April 2015 but dissolved by voluntary strike-off in February 2017. There is no evidence the business continues to operate under this or any other name.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gregory Fryer Associates.